Chemotherapy-Induced Myelosuppression Treatment Market Growth in 2019: Novartis AG, Amgen Inc., Pfizer Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., Myelo Therape and Forecast to 2028
A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y in 2019. Valued at nearly US$ 7 billion in 2018, gains are likely to be driven by a combination of multipronged factors, including,
View full press release